Skip to main content
Clinical Trials/EUCTR2018-001231-48-FR
EUCTR2018-001231-48-FRActive, not recruitingPhase 1

Effectiveness of oral corticosteroids in unilateral recurrent laryngeal nerve palsy after thyroidectomy

CHU DE POITIERS0 sites400 target enrollmentStarted: March 26, 2018Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
400

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing total or partial thyroidectomy (no lymphe node dissection)
  • Age = 18 yo
  • Informed consent, and signed
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 300
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

Exclusion Criteria

  • Patients undergoing thyroid cancer surgery (with lymphe node dissection)
  • Patients with pre operative recurrent laryngeal nerve palsy
  • Patients with bilateral recurrent laryngeal nerve palsy
  • Patients with allergy to Prednisolone
  • Patients with ongoing infection

Investigators

Similar Trials